Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Diplomat Pharmacy Inc. (DPLO)

4   0.01 (0.25%) 02-07 16:02
Open: 4 Pre. Close: 3.99
High: 4.01 Low: 4
Volume: 744,968 Market Cap: 304M
Diplomat Pharmacy Inc is a provider of pharmaceutical drugs in the United States. It generates its revenue through the sale of prescriptions drugs for serious diseases such as hepatitis and multiple sclerosis.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.014 - 4.033 4.033 - 4.05
Low: 3.953 - 3.975 3.975 - 3.995
Close: 3.966 - 4.001 4.001 - 4.031

Technical analysis

as of: 2020-02-14 4:28:03 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 4.77     One year: 4.85
Support: Support1: 3.98    Support2: 3.31
Resistance: Resistance1: 4.09    Resistance2: 4.15
Pivot: 3.99
Moving Average: MA(5): 4.00     MA(20): 4.00
MA(100): 4.58     MA(250): 5.40
MACD: MACD(12,26): -0.04     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 9.52     %D(3): 10.32
RSI: RSI(14): 44.99
52-week: High: 14.46  Low: 2.43  Change(%): -70.2
Average Vol(K): 3-Month: 233162  10-Days: 60904

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
DPLO has closed below upper band by 32.3%. Bollinger Bands are 97.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to DPLO's normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

ALEX, GNRC, CRMT shuffled in S&P index changes
Alexander & Baldwin (NYSE:ALEX) is moving into the S&P SmallCap 600 from the MidCap 400 to replace Diplomat Pharmacy (NYSE:DPLO), set to be acquired by Uni

WeissLaw LLP Investigates Diplomat Pharmacy, Inc. | MarketScreener
NEW YORK, Dec. 12, 2019 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Diplomat Pharmacy, Inc. in… | December 12, 2019

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 76.00
Shares Float (M) 52.48
% Held by Insiders 23.99
% Held by Institutions 84.09
Shares Short (K) 8090
Shares Short P. Month (K)

Stock Financials

EPS -8.679
Book Value (p.s.) 1.730
PEG Ratio 0.15
Profit Margin -12.47
Operating Margin -0.12
Return on Assets (ttm) -0.3
Return on Equity (ttm) -144.9
Qtrly Rev. Growth -5.3
Gross Profit (p.s.) 4.948
Sales Per Share
EBITDA (p.s.) 0.714
Qtrly Earnings Growth
Operating Cash Flow (M) 109.88
Levered Free Cash Flow (M) 105.01

Stock Valuations

P/E -0.46
P/E Growth Ratio
P/BV 2.31
P/S 0.05
P/CF 2.77

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.